Vericept Corp. (extinct)

Vericept Corp. (extinct)

Vericept Corp. (extinct)

Overview
Date Founded

1999

Headquarters

70 West Madison Street,Suite 1050,Chicago, IL 60602

Type of Company

Private

Employees (Worldwide)

5,001 - 10K

Industries

Computer Software
Other Business & Consulting Services
IT Consulting & Services

Company Description

Vericept Corp. was the provider of comprehensive compliance and data loss prevention solutions. It mitigated internal risk by providing enterprise-wide discovery, classification and prevention of the information exchanged inside and outside an organization. The company was founded in 1999 and was headquartered in Chicago, IL.

Contact Data
Trying to get in touch with decision makers at Vericept Corp.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Paths to Vericept Corp.
Potential Connections via
Relationship Science
You
Vericept Corp.
Recent Transactions
Details Hidden

Trustwave Holdings, Inc. purchases Vericept Corp.

Details Hidden

Vericept Corp. purchases Black White Box, Inc.

Investors
Details Hidden

Founder at Vericept Corp.

Details Hidden

Founder at Vericept Corp.

Details Hidden

William Blair Capital Partners (WBCP) focuses on private placements, PIPES and the investment of funds provided by partners of the firm. They invest in the following sectors: business services, financial services, consumer, healthcare services, healthcare products and technology.Within the business and financial services sectors, WBCP focuses on accounts receivable management, asset management services, data analytics, distribution services, education/educational services, interactive media, niche consulting, payment processing, payroll processing, research products/services, specialty insurance products and specialized marketing services.WBCP seeks investments in outstanding growth companies in the consumer sector. The firm looks for companies that need capital to expand through organic growth, regional expansion or through acquisition of other market players. They focus primarily on two niches within the consumer segment: (1) companies involved in the sale of new and novel products and services to the consumer and companies involved in the sale of well-established products in new and novel ways. WBCP seeks to invest in growing, well-managed companies with strong management teams that are, or have the potential to become, leaders in their market niche.Within the healthcare sector, WBCP invests primarily in the medical devices, biopharmaceuticals and healthcare services industries. The firm looks for innovative companies with products that address unmet medical needs. They are particularly interested in therapeutic areas in which relatively little capital has been historically deployed, including gastroenterology, neurology/neurosurgery and cosmetic surgery and aesthetics. They may also consider investment opportunities in the orthopedic, spine and cardiovascular segments.In the biopharmaceutical industry, WBCP invests primarily in companies that have late-stage (phase II clinical trials or later) compounds or that have approved products. The firm also pursues opportunities to start and nurture pharmaceutical companies in the dermatology, neurology, rheumatology and gastroenterology specialties. WBCP also invests in small market companies with annual revenues of $50 million to $300 million that have not generated strong commercial or development interest from large pharmaceutical companies.WBCP considers investments in healthcare companies that provide services to patients in the outpatient or short-stay settings and in companies that provide outsourced business services to larger healthcare providers such as hospitals or surgery centers. The firm is particularly interested in service companies that pursue segments of the healthcare economy in which the patient pays directly for the service or that provide business-to-business services to healthcare providers. They also invest in companies that provide medical services to governmental healthcare programs such as Medicare and Medicaid.WBCP invests technology companies primarily in the following areas: wireless semiconductors, consumer electronic semiconductors/software, wireless Internet and software as service (SaaS). They firm seeks to invest in companies with (1) platform technology including core technology can be applied to multiple markets across multiple product lines (2) scaleable and capital efficient business models (3) market opportunities that have been validated by customers (4) disruptive technology that is non-disruptive to implement (5) a defensible and sustainable technology lead (6) multiple exit opportunities including acquisition and IPO and (7) compelling growth rates appropriate for their business model. WMCP invests in companies that require funds for product development, sales, marketing and operations. They do not invest in technology development.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vericept Corp.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vericept Corp.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vericept Corp..